Skip to main content

Sensus Healthcare Inc(SRTS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low3.85
Day High4.03
Open:4.01
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Sensus Healthcare Inc

Select a category then submit the form to load news
Tipranks
Analysts Conflicted on These Healthcare Names: Sensus Healthcare (SRTS), NeoGenomics (NEO) and COMPASS Pathways (CMPS)
Tipranks
Sensus Healthcare Bets on 2026 Reimbursement Rebound
Tipranks
Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), Aethlon Medical (AEMD) and American Well (AMWL)
Motley Fool
Sensus Healthcare SRTS Q4 2025 Earnings Transcript
Tipranks
Sensus Healthcare Appoints Eric Sachetta as Director
Business Wire
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
Business Wire
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
Tipranks
Sensus Healthcare’s Earnings Call: Mixed Signals and Optimistic Outlook
Tipranks
Lake Street Sticks to Their Buy Rating for Sensus Healthcare (SRTS)
Motley Fool
Sensus SRTS Q3 2025 Earnings Call Transcript
Business Wire
Sensus Healthcare Reports Third Quarter 2025 Financial Results
Business Wire
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
Business Wire
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
Business Wire
Sensus Healthcare Announces the Passing of Director Bill McCall
Business Wire
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
Business Wire
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
Business Wire
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
Newsfile
Ongoing Sensus Healthcare, Inc. (SRTS) Investigation: Protect Your Rights - Contact Levi & Korsinsky
Tipranks
Sensus Healthcare Reports Q2 2025 Financial Results
Tipranks
Sensus Healthcare (SRTS) Receives a Buy from Roth MKM
Motley Fool
Sensus (SRTS) Q2 Revenue Falls 21%
Business Wire
Sensus Healthcare Reports Second Quarter 2025 Financial Results
Tipranks
Sensus Healthcare (SRTS) Gets a Buy from Lake Street
Business Wire
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
Business Wire
Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
Tipranks
Roth MKM Sticks to Its Buy Rating for Sensus Healthcare (SRTS)
Tipranks
Sensus Healthcare (SRTS) Gets a Buy from Lake Street
ACCESS Newswire
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
MarketBeat
How 2022's Biggest Healthcare Gainers Could Fare In 2023
Barchart
Take Advantage of the Dip: 3 Top Stocks To Consider
Charts, tickers, traders - shutterstock_1033516756
Barchart
Take Advantage of the Dip: 3 Top Stocks To Consider
Charts, tickers, traders - shutterstock_1033516756
Globe Newswire
Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities

Profile

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.